HealthEdge Adds Veteran Healthcare Executive Bob Cunard

TAMPA, FLORIDA – June 2017 – HealthEdge Investment Partners, LLC (“HealthEdge” or the “Fund”) is pleased to announce that it has added Bob Cunard to its team of Operating Partners.

Mr. Cunard currently serves as CEO of Fund III portfolio company The Columbus Organization, which is the nation’s leading provider of on-site case management, professional staffing, and consultative services, focusing exclusively on agencies that serve individuals with special needs.  In addition to his role as CEO of The Columbus Organization, Mr. Cunard will support the evaluation of investment opportunities for HealthEdge Fund III.

Prior to joining HealthEdge, Mr. Cunard was most recently CEO of Aurobindo Pharma USA, Inc., the largest subsidiary of Aurobindo Pharma Limited, an API and finished dosage form generic manufacturer headquartered in Hyderabad, India, with annual revenue in excess of $2.0 billion.  He joined Aurobindo in 2011 and led five years of significant growth, generating 33% compound annual growth in the U.S. business, contributing significantly to the 15x growth in corporate market capitalization to $6.0 billion. 

Mr. Cunard brings more than 25 years of experience in U.S. pharmaceuticals from the perspectives of wholesaler, retailer, and manufacturer.  Previously, Bob held numerous executive positions in sales and marketing with some of the generic pharmaceutical industry’s most notable companies, including Mylan Laboratories and Teva Pharmaceuticals.  He began his career with Value Drug Company, a wholesale cooperative for independent retail pharmacy before joining Rite Aid Corporation, one of the nation’s largest pharmacy chains.

HealthEdge Partner Jeff Thompson said, “We are excited to add an executive of Bob’s caliber to our team. Bob is an experienced leader whom we know well, with a track record of building highly successful healthcare companies.”

About HealthEdge

HealthEdge Investment Partners, LLC is an operation-oriented private equity firm founded in 2005 that focuses exclusively on the healthcare industry. HealthEdge seeks to achieve superior returns by investing in businesses that benefit from the knowledge, experience, and network of relationships of its partners. HealthEdge’s partners have more than 100 years of combined operating experience in healthcare as CEOs and investors. For more information on HealthEdge, visit www.healthedgepartners.com.

For more information, please contact Phil Dingle at HealthEdge Investment Partners at (813) 490-7101.